Circulating Tumor Cell Counts/change for Outcome Prediction in Patients with Extensive-Stage Small-Cell Lung Cancer
- 3 February 2016
- journal article
- clinical trial
- Published by Taylor & Francis in Future Oncology
- Vol. 12 (6) , 789-799
Abstract
Aims: As data on the use of circulating tumor cells (CTCs) to predict patient outcomes in extensive-stage small-cell lung cancer (ES-SCLC) remain inconclusive, we investigated the clinical value of CTC determination in an open-label, multicenter study of 91 patients with newly diagnosed ES-SCLC. Materials & methods: Blood CTC counts were determined using the CellSearch® system at baseline, after the second cycle of chemotherapy, and on disease progression. Results & conclusion: Following the second cycle of treatment, CTC numbers and the change in CTCs were strong, significant and independent indicators for both progression-free survival and overall survival in ES-SCLC. The CTC change was associated with both refractory disease (response to initial therapy ≤3 months) and sensitive disease (response to initial therapy >3 months).Keywords
This publication has 25 references indexed in Scilit:
- Biology, detection, and clinical implications of circulating tumor cellsEMBO Molecular Medicine, 2014
- Blood-Based Analyses of Cancer: Circulating Tumor Cells and Circulating Tumor DNACancer Discovery, 2014
- Validation and clinical utility of prostate cancer biomarkersNature Reviews Clinical Oncology, 2013
- Circulating Tumor Cells Predict Survival Benefit from Treatment in Metastatic Castration-Resistant Prostate CancerClinical Cancer Research, 2008
- Relationship of Circulating Tumor Cells to Tumor Response, Progression-Free Survival, and Overall Survival in Patients With Metastatic Colorectal CancerJournal of Clinical Oncology, 2008
- Circulating Tumor Cell Number and Prognosis in Progressive Castration-Resistant Prostate CancerClinical Cancer Research, 2007
- Circulating Tumor Cells versus Imaging—Predicting Overall Survival in Metastatic Breast CancerClinical Cancer Research, 2006
- Small-cell lung cancerThe Lancet, 2005
- Circulating Tumor Cells: A Novel Prognostic Factor for Newly Diagnosed Metastatic Breast CancerJournal of Clinical Oncology, 2005
- Circulating Tumor Cells, Disease Progression, and Survival in Metastatic Breast CancerNew England Journal of Medicine, 2004